12,372 trials
Type 2 Diabetes Mellitus
Primary: Number of Participants With Adverse Events. — 16; 3; 7; 5 participants
Schizophrenia · Schizoaffective Disorder
Primary: Time to Relapse of Psychotic Symptoms During 6 Weeks — 23.8; 16.9; 17.3 days
Vaccines, Pneumococcal
Primary: Percentage of Participants Achieving Predefined Meningococcal C Serum Bactericidal Assay (SBA) Titer of ≥ 1:8, and a Predefined Antibody Level for Diphtheria in 13vPnC…
Graft Rejection
Primary: Percentage of Participants With Composite Efficacy Failure at 12 Months — 35.1; 35.1; 33.6 Percentage of participants
Multiple Sclerosis
Primary: Change From Baseline in Mean Spasticity 0-10 Numerical Rating Scale (NRS) Score During the Last 14 Day of Treatment (End of Treatment) — -1.22; -0.91 units on a scale…
Pain · Peripheral Neuropathy
Primary: Change From Baseline in Mean Daily Pain Severity on a 0-10 Numerical Rating Scale Score at the End of Treatment (Average of Last 7 Days Treatment) — 0.57; -0.49 units on…
Pneumococcal Vaccines
Primary: Percentage of Participants Achieving Antibody Level ≥0.35μg/mL in 13vPnC Manufacturing Scale Group Relative to 13vPnC Pilot Scale Group After the 3-Dose Infant Series…
Vaccines, Pneumococcal
Primary: Percentage of Participants Achieving a Meningococcal C Serum Bactericidal Assay (SBA) Titer ≥1:8 and Predefined Antibody Levels for Pertussis and Haemophilus Influenzae…
Pneumococcal Infections
Primary: Percentage of Participants Achieving Antibody Level ≥0.35μg/mL After Vaccination — 100.0; 100.0; 99.3; 98.8 percentage of participants
Bronchial Asthma
Primary: Morning Peak Expiratory Flow (PEF) — 12.88; 13.78; 4.59 Liters/min
Vaccines, Pneumococcal
Primary: Percentage of Participants Achieving Antibody Level ≥0.35μg/mL in 13vPnC+P80 Group Relative to 13vPnC-80 Group After the Infant Series — 93.3; 94.1; 60.9; 66.4…
Vaccines, Pneumococcal
Primary: Percentage of Participants Achieving Predefined Antibody Levels for Diphtheria, Tetanus, Hemophilus Influenza Type b (Hib), Poliomyelitis (Type 1, 2, 3), Pertussis Toxin…
Squamous Cell Carcinoma of the Head and Neck
Primary: Best Overall Response (BOR) — 68.2 percentage of participants
Asthma
Primary: Time to First Severe Asthma Exacerbation — 120.3; 103.7 days
Palliative Care · Pain · Cancer
Primary: The Change in Mean Pain Numerical Rating Scale (NRS) Score From Baseline to the End of the Treatment. — -1.32; -0.93; -0.73 units on a scale — p=0.014